Will MediBuddy beat Big Players with Big Pockets?

▴ MediBuddy will beat Big Players with Big Pockets?
In total, all the funds raised by MediBuddy since its inception is $67.1 million. E-pharmacy giants like Netmeds have $99 million funds and Pharmeasy $1.2 billion funds.

MediBuddy is your medical pal that provides you access to high-quality healthcare 24x7. Co-founded by Satish Kannan and Enbasekar (IIT Madras alumni), MediBuddy lends you highly skilled doctors, medicines and lab tests that you can gain consultations or bookings within the convenience of your home. It gives you a large network of 90,000 doctors, 7000 hospitals and 3000 diagnostic centres across India. It is spread across 23000 Indian pin-codes which cover 95% of the entire Indian landscape. An estimate claims, MediBuddy caters to the healthcare needs of 3 crore Indians.

Their platform provides online consultancy for 18 specialities like Cardiologist, General Physicist, Paediatrics, Psychiatrist, Neurologist, Dermatologist and more. An estimate claims that one can save up to 60% of consultations. Seeing the linguistic diversity as they are in 22 cities of India, they provide consultations in many Indian languages. 

Last year in June, DocsApp (an online doctor consultation platform) merged with MediBuddy. The merger was made to establish market leadership in the online health space. Both the companies now function under the name of MediBuddy and would create a comprehensive digital healthcare platform. The merger raised $20 million or Rs 150 crores in Series B round. The funding was led by Bessemer Venture Partners, Mitsui Sumitomo Fusian Capital, Beyond Next ventures and Facebook’s angel investors. The combined worth of both the companies is at $164-167 million or Rs 1,190-1,210 crores.

In February 2021, MediBuddy closed its Series B funding round and raised $40 million or Rs 292 crores. They also raised Rs 25 crores from Stride ventures’ venture debt fund. Stride Ventures had kept a target corpus of Rs 1000 crores that would be invested in early to late-stage startups. Stride Ventures had earlier announced in its Fund II to invest Rs 9.6 million and Rs 70 crores. This year in June, MediBuddy had its last funding round of Debt - III for $3.4 million. 

MediBuddy has till now raised $67.1 million. How will a company with so little amount of funds give competition to online healthcare giants like 1mg with their $204.6 million funds, Netmeds with $99 million funds and Pharmeasy - $1.2 billion funds.

Can MediBuddy with its low funds beat the big players with big pockets?

Tags : #medibuddy #satishkannan #enbasekar #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026